Whilst we discovered that ATM and ATR (bot not DNA-PK) were significantly elevated in T2DM-SMC, pharmacological and siRNA-mediated modulation revealed that it was only inhibition of ATR (single strand DNA breaks) that led to reduced SV-SMC proliferation. Here, PRKDC is linked to type 2 diabetes mellitus.